Literature DB >> 14597127

Fumonisin B1-induced apoptosis is associated with delayed inhibition of protein kinase C, nuclear factor-kappaB and tumor necrosis factor alpha in LLC-PK1 cells.

Neera V Gopee1, Quanren He, Raghubir P Sharma.   

Abstract

Fumonisin B1 (FB1), the most potent of the fumonisin mycotoxins, is a carcinogen and causes a wide range of species-specific toxicoses. FB1 modulates the activity of protein kinase C (PKC), a family of phospholipid-dependent serine/threonine kinases that play important role in modulating a variety of biologic responses ranging from regulation of cell growth to cell death. Although it has been demonstrated that FB1 induces apoptosis in many cell lines, the precise mechanism of apoptosis is not fully understood. In this study, we investigated the membrane localization of various PKC isoforms, PKC enzyme activity, and its downstream targets, namely nuclear factor-kappa B (NF-kappaB), tumor necrosis factor alpha (TNFalpha), and caspase 3, in porcine renal epithelial (LLC-PK1) cells. FB1 repressed cytosol to membrane translocation of PKC-alpha, -delta, -epsilon, and -zeta isoforms over 24-72 h. The FB1-induced membrane PKC repression was corroborated by a concentration-dependent decrease in total PKC activity. Exposure of cells to phorbol 12-myristate 13-acetate (PMA) for this duration also resulted in repressed PKC membrane localization and activity comparable to FB1. Exposure of cells to FB1 (10 microM) was associated with inhibition of cytosol to nuclear translocation of NF-kappaB and NF-kappaB-DNA binding at 72 h. The expression of TNFalpha was significantly inhibited at 24 and 48 h in response to 1 and 10 microM FB1. Increased caspase 3 activity was observed in LLC-PK1 cells exposed to > or =1 microM FB1 at 48 h. PMA also increased the caspase 3 activity at 24 and 48 h. Results suggest that FB1-induced apoptosis involves the activation of caspase 3, which is associated with the repression of PKC and possibly its down-stream effectors, NF-kappaB and TNFalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597127     DOI: 10.1016/s0009-2797(03)00102-9

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

1.  The African Fusarium/maize disease.

Authors:  Michael F Dutton
Journal:  Mycotoxin Res       Date:  2009-01-14       Impact factor: 3.833

Review 2.  Comparative pathobiology of fungal pathogens of plants and animals.

Authors:  Martin B Dickman; Paul de Figueiredo
Journal:  PLoS Pathog       Date:  2011-12-15       Impact factor: 6.823

3.  Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1.

Authors:  Ali Mohammad Alizadeh; Fahimeh Mohammadghasemi; Kazem Zendehdel; Zahra Kamyabi-Moghaddam; Abbas Tavassoli; Fatemeh Amini-Najafi; Alireza Khosravi
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

Review 4.  Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis.

Authors:  Alessandra Mezzelani; Martina Landini; Francesco Facchiano; Maria Elisabetta Raggi; Laura Villa; Massimo Molteni; Barbara De Santis; Carlo Brera; Anna Maria Caroli; Luciano Milanesi; Anna Marabotti
Journal:  Nutr Neurosci       Date:  2014-01-21       Impact factor: 4.994

5.  Deoxynivanelol and fumonisin, alone or in combination, induce changes on intestinal junction complexes and in E-cadherin expression.

Authors:  Karina Basso; Fernando Gomes; Ana Paula Loureiro Bracarense
Journal:  Toxins (Basel)       Date:  2013-11-28       Impact factor: 4.546

6.  Phytic acid decreases deoxynivalenol and fumonisin B1-induced changes on swine jejunal explants.

Authors:  Elisângela Olegário da Silva; Juliana Rubira Gerez; Thalisie do Carmo Drape; Ana Paula F R L Bracarense
Journal:  Toxicol Rep       Date:  2014-05-29

Review 7.  Toxic Mechanism and Biological Detoxification of Fumonisins.

Authors:  Linkai Qu; Lei Wang; Hao Ji; Yimeng Fang; Pengyu Lei; Xingxing Zhang; Libo Jin; Da Sun; Hao Dong
Journal:  Toxins (Basel)       Date:  2022-03-01       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.